Supplemental data

The following information is presented as supplemental data as required by the indentures governing the Company’s senior notes.

Condensed Consolidating Statements of Income



	Consolidated Total			Physician Groups			Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
For The Three Months Ended March 31, 2018	Consolidated Total			Physician Groups			Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
Patient service operating revenues	$	2,591,074		$	—		$	—	$	2,591,074
Provision for uncollectible accounts	25,545			—			—		25,545
Net patient service operating revenues	2,616,619			—			—		2,616,619
Other revenues	232,825			—			—		232,825
Total net operating revenues	2,849,444			—			—		2,849,444
Operating expenses	2,438,758			—			—		2,438,758
Operating income	410,686			—			—		410,686
Debt expense, including refinancing charges	(113,516		)	—			—		(113,516		)
Other income	4,582			—			—		4,582
Income tax expense	70,737			—			—		70,737
Net income from continuing operations	231,015			—			—		231,015
Net (loss) income from discontinued operations, net of tax	(5,786		)	7,397			490		(13,673		)
Net income	225,229			7,397			490		217,342
Less: Net income attributable to noncontrolling interests	(46,543		)	(6,543		)	—		(40,000		)
Net income attributable to DaVita Inc.	$	178,686		$	854		$	490	$	177,342


(1)	After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Statements of Comprehensive Income



	Consolidated Total			Physician Groups			Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
For The Three Months Ended March 31, 2018	Consolidated Total			Physician Groups			Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
Net income	$	225,229		$	7,397		$	490	$	217,342
Other comprehensive income	22,468			—			—		22,468
Total comprehensive income	247,697			7,397			490		239,810
Less: Comprehensive income attributable to the noncontrolling interests	(46,543		)	(6,543		)	—		(40,000		)
Comprehensive income attributable to DaVita Inc.	$	201,154		$	854		$	490	$	199,810


(1)	After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Balance Sheets



	Consolidated Total		Physician Groups		Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
As of March 31, 2018	Consolidated Total		Physician Groups		Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
Cash and cash equivalents	$	358,874	$	—	$	—	$	358,874
Restricted cash and equivalents	88,744		—		—		88,744
Accounts receivable, net	1,830,590		—		—		1,830,590
Other current assets	671,082		133,199		—		537,883
Current assets held for sale	5,724,265		319,968		3,223		5,401,074
Total current assets	8,673,555		453,167		3,223		8,217,165
Property and equipment, net	3,185,223		—		—		3,185,223
Amortizable intangibles, net	113,366		—		—		113,366
Other long-term assets	331,636		—		—		331,636
Goodwill	6,638,592		—		—		6,638,592
Total assets	$	18,942,372	$	453,167	$	3,223	$	18,485,982
Current liabilities	$	1,692,898	$	—	$	—	$	1,692,898
Current liabilities held for sale	1,254,625		328,493		—		926,132
Payables to parent	—		—		3,223		(3,223		)
Long-term debt and other long-term liabilities	10,178,267		—		—		10,178,267
Noncontrolling interests subject to put provisions	1,034,501		—		—		1,034,501
Total DaVita Inc. shareholders’ equity	4,580,680		124,674		—		4,456,006
Noncontrolling interests not subject to put provisions	201,401		—		—		201,401
Shareholders’ equity	4,782,081		124,674		—		4,657,407
Total liabilities and shareholder’s equity	$	18,942,372	$	453,167	$	3,223	$	18,485,982


(1)	After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Statements of Cash Flows



	Consolidated Total			Physician Groups			Unrestricted Subsidiaries			Company and Restricted Subsidiaries⁽¹⁾
For The Three Months Ended March 31, 2018	Consolidated Total			Physician Groups			Unrestricted Subsidiaries			Company and Restricted Subsidiaries⁽¹⁾
Cash flows from operating activities:
Net income	$	225,229		$	7,397		$	490		$	217,342
Changes in operating and intercompany assets and liabilities and non-cash items included in net income	137,310			(20,189		)	(490		)	157,989
Net cash provided by (used in) operating activities	362,539			(12,792		)	—			375,331
Cash flows from investing activities:
Additions of property and equipment	(232,443		)	(1,165		)	—			(231,278		)
Acquisitions	(16,582		)	—			—			(16,582		)
Proceeds from asset and business sales	18,535			—			—			18,535
Investments and other items	30,362			(541		)	—			30,903
Net cash used in investing activities	(200,128		)	(1,706		)	—			(198,422		)
Cash flows from financing activities:
Long-term debt	104,673			—			—			104,673
Intercompany	—			1,082			—			(1,082		)
Other items	(327,220		)	—			—			(327,220		)
Net cash (used in) provided by financing activities	(222,547		)	1,082			—			(223,629		)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	6,668			—			—			6,668
Net decrease in cash, cash equivalents and restricted cash	(53,468		)	(13,416		)	—			(40,052		)
Less: Net increase (decrease) in cash, cash equivalents and restricted cash from discontinued operations	17,834			(13,416		)	—			31,250
Net decrease in cash, cash equivalents and restricted cash from continuing operations	(71,302		)	—			—			(71,302		)
Cash, cash equivalents and restricted cash of continuing operations at beginning of the year	518,920			—			—			518,920
Cash, cash equivalents and restricted cash of continuing operations at end of the period	$	447,618		$	—		$	—		$	447,618


(1)	After elimination of the unrestricted subsidiaries and the physician groups.